United States ex rel. Saldivar v. Fresenius Medical Care Holdings, Inc.

ORDER

Amy Totenberg, United States District Judge

This qui tarn action arises out of allegations that Defendant Fresenius Medical Care Holdings, Inc. d/b/a Fresenius Medical Care North America (“Fresenius” or “FMCNA”) violated the False Claims Act (“FCA”), 31 U.S.C. § 3729, on a'regular basis when it submitted requests for reimbursement for lucrative dialysis drugs that it received for free. Relator Chester Sal-divar alleges that Fresenius billed Medicare for administration of overfill — a varying amount of extra medicine contained in individual vials the purpose of which is to facilitate…